These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33918207)

  • 21. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.
    Huang Y; Zhang Y; Wan T; Mei Y; Wang Z; Xue J; Luo Y; Li M; Fang S; Pan H; Wang Q; Fang J
    Cell Biol Toxicol; 2021 Feb; 37(1):113-128. PubMed ID: 33130971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.
    Larmonier CB; Uno JK; Lee KM; Karrasch T; Laubitz D; Thurston R; Midura-Kiela MT; Ghishan FK; Sartor RB; Jobin C; Kiela PR
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1079-91. PubMed ID: 18818316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy.
    Liu C; Yan X; Zhang Y; Yang M; Ma Y; Zhang Y; Xu Q; Tu K; Zhang M
    J Nanobiotechnology; 2022 Apr; 20(1):206. PubMed ID: 35488343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire.
    Suh JH; Saba JD
    Transl Cancer Res; 2015 Oct; 4(5):469-483. PubMed ID: 27011900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
    Jurenka JS
    Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
    Yao Y; Liu Y; Xu Q; Mao L
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MYTHS of
    James SD; Hawkins AT; Um JW; Ballard BR; Smoot DT; M'Koma AE
    Jpn J Gastroenterol Hepatol; 2020; 3(2):. PubMed ID: 37584007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease.
    Sreedhar R; Arumugam S; Thandavarayan RA; Karuppagounder V; Watanabe K
    Drug Discov Today; 2016 May; 21(5):843-9. PubMed ID: 26995272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice.
    Mouzaoui S; Rahim I; Djerdjouri B
    Int Immunopharmacol; 2012 Jan; 12(1):302-11. PubMed ID: 22036766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease.
    Gowd V; Kanika ; Jori C; Chaudhary AA; Rudayni HA; Rashid S; Khan R
    J Nutr Biochem; 2022 Nov; 109():109101. PubMed ID: 35777588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical therapy of inflammatory bowel disease for the 21st century.
    Robinson M
    Eur J Surg Suppl; 1998; (582):90-8. PubMed ID: 10029372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
    Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptive eating as part of the journey in inflammatory bowel disease: Lessons learned from lived experience.
    Nowlin S; Manning L; Keefer L; Gorbenko K
    Clin Nutr ESPEN; 2021 Feb; 41():299-304. PubMed ID: 33487280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Old but Fancy: Curcumin in Ulcerative Colitis-Current Overview.
    Pituch-Zdanowska A; Dembiński Ł; Banaszkiewicz A
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.
    Alimohammadi N; Koosha F; Rafeian-Kopaei M
    Curr Pharm Des; 2020; 26(22):2668-2675. PubMed ID: 32250220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways.
    Almarzooqi S; Venkataraman B; Raj V; Alkuwaiti SAA; Das KM; Collin PD; Adrian TE; Subramanya SB
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products.
    Bilski J; Wojcik D; Danielak A; Mazur-Bialy A; Magierowski M; Tønnesen K; Brzozowski B; Surmiak M; Magierowska K; Pajdo R; Ptak-Belowska A; Brzozowski T
    Curr Pharm Des; 2020; 26(25):2936-2950. PubMed ID: 32338209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.